	PEOPLE	CENTERS	COMMUNITIES	RESEARCH STORIES

TARGETING A STRESS-DERIVED IMMUNOSUPPRESSIVE ADENOSINE PATHWAY IN TUMORS RESISTANT TO CHECKPOINT INHIBITORS

TARGETING A STRESS-DERIVED IMMUNOSUPPRESSIVE ADENOSINE PATHWAY IN TUMORS RESISTANT TO CHECKPOINT INHIBITORS

PI: Yong Qin

Sponsor: US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND

Pharmacy

Amount awarded: $573,908

This project investigates immunotherapies in resistant cancers, such as pancreatic cancer.

Posting date: Mon, 11/09/2020

Award start date: Sun, 11/01/2020

Award end date: Mon, 10/31/2022

© 2013 The University of Texas at El Paso | Terms Of Use | Privacy Statement | Questions or Comments about this site? Click here

Some of the content on this web site includes information taken from UTEP's Digital Measures and University Communications.
This material is based upon work supported in part by the Office of Research and Sponsored Projects and the National Science Foundation under Grant No. DUE-0963648 and CREST Grant No. HRD-1242122. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation (NSF).